HIT Consultant
HIT Consultant is a recognized digital media platform dedicated to healthcare technology. It offers compelling interviews, engaging videos, podcasts, and thorough insights that contribute to the evolving world of healthcare technology.
Outlet metrics
Global
#855838
United States
#310402
Health/Health
#5624
Articles
-
1 week ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Omada Health, the virtual between-visit healthcare provider released new data demonstrating that its GLP-1 companion program significantly improves persistence rates for GLP-1 medications. – The analysis found that members in Omada’s program achieved weight loss results similar to those seen in controlled research settings, underscoring the importance of comprehensive support for individuals on these transformative medications.
-
1 week ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Quest Health Solutions, a national leader in diabetes care, today announced compelling results from its Remote Patient Monitoring (RPM) program, developed in partnership with the digital health company Rimidi. In just two months, the Quest Health RPM Services—powered by Rimidi’s EHR-integrated platform—led to an 11% improvement in average blood glucose readings among participating patients.
-
1 week ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Glytec, a provider of an AI-powered technology platform for diabetes and related conditions, secures a $36M growth investment led by Savitr Capital and Hayfin Capital Management.
-
1 week ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Erlanger, a nationally-acclaimed, multi-hospital health system, today announced a strategic partnership with Qventus, the industry’s premier provider of AI-based care operations automation software. The collaboration is aimed at driving strategic surgical growth and increasing patient access to advanced, minimally invasive da Vinci procedures.
-
1 week ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the launch of its DIRECT-AI registry study. This new study will assess how the ArteraAI Prostate Test influences treatment decision-making between clinicians and patients with localized prostate cancer.
HIT Consultant journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://hitconsultant.netTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →